Prefillable Reusable Injection Devices to 2026 • PRJ485K • April 2022 • US$3,850
The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions. Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process.
Order OnlinePrefillable Reusable Injection Devices – What You Will Learn
• What are the dynamics of the shifting landscape for prefillable reusable injectable drug delivery and the market impact of new and evolving devices?
• What are the market drivers influencing injector device designs, feature/functionality, product branding, competing technologies and commercial development?
• What are the key characteristics of the major injection device market segments and what is the impact of market demographics, and competing business strategies?
• What is the current market for prefillable reusable injector demand and what will it be in 2026?
• Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
• What is the impact of economic, technology, and regulatory factors on prefillable reusable injectable drug delivery demand?
Summary of Contents
Executive Summary
Device and Packaging Technology Advances
Shifting Patient Demographics
Evolution in Drug Development
Diseases and Indications
Device Selection Factors
Market Segmentation
Product Features & Ease of Use
Supply Chain Factors
Device Classes
Pen Injectors
Autoinjectors
Therapeutic Segments
Hematopoietics
Antivirals
Hormone Replacement
Parkinson’s Disease
Hematopoietics
Reproductive Health
Market Factors
Regulatory Issues
DTC Marketing
Patient Education
Company Profiles
For more information click HERE